Sagaert X - Search Results

1

Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Van Cutsem E, et al. Among authors: sagaert x. Lancet. 2016 Nov 26;388(10060):2654-2664. doi: 10.1016/S0140-6736(16)30354-3. Epub 2016 May 5. Lancet. 2016. PMID: 27156933 Review.

2

Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development.

Sagaert X, Van Cutsem E, De Hertogh G, Geboes K, Tousseyn T. Sagaert X, et al. Nat Rev Gastroenterol Hepatol. 2010 Jun;7(6):336-46. doi: 10.1038/nrgastro.2010.58. Epub 2010 May 4. Nat Rev Gastroenterol Hepatol. 2010. PMID: 20440281 Review.

3

The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer.

Lambrecht M, Deroose C, Roels S, Vandecaveye V, Penninckx F, Sagaert X, van Cutsem E, de Keyzer F, Haustermans K. Lambrecht M, et al. Among authors: sagaert x. Acta Oncol. 2010 Oct;49(7):956-63. doi: 10.3109/0284186X.2010.498439. Acta Oncol. 2010. PMID: 20586658 Clinical Trial.

4

A cheesy diagnosis.

Wisanto E, D'Hondt M, Aerts R, Geboes K, De Hertogh G, Sagaert X. Wisanto E, et al. Among authors: sagaert x. Lancet. 2010 Aug 14;376(9740):564. doi: 10.1016/S0140-6736(10)60875-6. Lancet. 2010. PMID: 20709234 No abstract available.

5

T(11;18)(q21;q21)-positive gastrointestinal MALT lymphomas are heterogeneous with respect to the V(H) gene mutation status.

Sagaert X, Maes B, Vanhentenrijk V, Baens M, Van Cutsem E, Hertogh GD, Geboes K, Tousseyn T. Sagaert X, et al. World J Gastrointest Oncol. 2011 Feb 15;3(2):24-32. doi: 10.4251/wjgo.v3.i2.24. World J Gastrointest Oncol. 2011. PMID: 21364843 Free PMC article.

6

Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study.

Van Cutsem E, Tejpar S, Vanbeckevoort D, Peeters M, Humblet Y, Gelderblom H, Vermorken JB, Viret F, Glimelius B, Gallerani E, Hendlisz A, Cats A, Moehler M, Sagaert X, Vlassak S, Schlichting M, Ciardiello F. Van Cutsem E, et al. Among authors: sagaert x. J Clin Oncol. 2012 Aug 10;30(23):2861-8. doi: 10.1200/JCO.2011.40.9243. Epub 2012 Jul 2. J Clin Oncol. 2012. PMID: 22753904 Clinical Trial.

7

Investigation of possible endogenous hypoxia markers in colorectal cancer.

Verstraete M, Debucquoy A, Devos E, Sagaert X, Penninckx F, Begg A, Haustermans K. Verstraete M, et al. Among authors: sagaert x. Int J Radiat Biol. 2013 Jan;89(1):9-15. doi: 10.3109/09553002.2012.715789. Epub 2012 Aug 24. Int J Radiat Biol. 2013. PMID: 22852555 Clinical Trial.

8

Analysis of the formalin-fixed paraffin-embedded tissue proteome: pitfalls, challenges, and future prospectives.

Maes E, Broeckx V, Mertens I, Sagaert X, Prenen H, Landuyt B, Schoofs L. Maes E, et al. Among authors: sagaert x. Amino Acids. 2013 Aug;45(2):205-18. doi: 10.1007/s00726-013-1494-0. Epub 2013 Apr 17. Amino Acids. 2013. PMID: 23592010 Free article. Review.

9

Proteomic analysis of formalin-fixed paraffin-embedded colorectal cancer tissue using tandem mass tag protein labeling.

Maes E, Valkenborg D, Mertens I, Broeckx V, Baggerman G, Sagaert X, Landuyt B, Prenen H, Schoofs L. Maes E, et al. Among authors: sagaert x. Mol Biosyst. 2013 Nov;9(11):2686-95. doi: 10.1039/c3mb70177h. Mol Biosyst. 2013. PMID: 23986405

10

Hypoxia-driven gene expression is an independent prognostic factor in stage II and III colon cancer patients.

Dekervel J, Hompes D, van Malenstein H, Popovic D, Sagaert X, De Moor B, Van Cutsem E, D'Hoore A, Verslype C, van Pelt J. Dekervel J, et al. Among authors: sagaert x. Clin Cancer Res. 2014 Apr 15;20(8):2159-68. doi: 10.1158/1078-0432.CCR-13-2958. Epub 2014 Jan 31. Clin Cancer Res. 2014. PMID: 24486594 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page